| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |